Anacor Pharmaceuticals, Inc.
(NASDAQ : ANAC)

( )
ANAC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.06%125.870.6%$873.95m
PFEPfizer Inc.
-0.11%37.320.9%$678.99m
ABBVAbbVie, Inc.
-1.16%88.912.1%$588.97m
MRKMerck & Co., Inc.
0.02%62.520.6%$527.86m
BMYBristol-Myers Squibb Company
0.32%56.721.4%$314.96m
LLYEli Lilly and Company
-1.05%88.491.0%$253.24m
NVSNovartis AG Sponsored ADR
1.84%82.290.2%$188.53m
AZNAstraZeneca PLC Sponsored ADR
0.39%37.181.3%$135.85m
GSKGlaxoSmithKline plc Sponsored ADR
2.90%41.870.2%$105.42m
SNYSanofi Sponsored ADR
1.12%42.380.2%$102.48m
NVONovo Nordisk A/S Sponsored ADR Class B
1.24%50.430.1%$78.67m
LCILannett Company, Inc.
-3.13%12.4037.9%$7.01m
AKTXAkari Therapeutics Plc Sponsored ADR
0.97%2.081.7%$0.20m
EPIXESSA Pharma Inc
-3.53%3.550.0%$0.03m

Company Profile

Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA.